Genetics of Parkinson's disease

被引:124
作者
Nussbaum, RL
Polymeropoulos, MH
机构
[1] Lab. of Genetic Diseases Research, Natl. Hum. Genome Research Institute, Bethesda
关键词
D O I
10.1093/hmg/6.10.1687
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
For the past 40 years, research into Parkinson's disease (PD) has been predominantly the province of epidemiologists interested in pursuing the connection between the disease and environmental factors such as viral infection or neurotoxins, Hereditary influences were actually discounted because of a high monozygotic twin discordance rate found in studies that were later shown to be inadequate and inconclusive, There has recently been a resurgence of interest in investigating hereditary factors in PD when it became more and more apparent that a positive family history was a major risk factor for the disease. Meanwhile, it also became increasingly apparent from neuropathological studies that the common, idiopathic form of Parkinson's disease had, in fact, a pathological correlate, i.e., the existence of Lewy bodies, an eosinophilic cytoplasmic inclusion body, distributed diffusely throughout the substnatia nigra, hypothalamus, hippocampus, autonomic ganglia and olfactory tracts. Although candidate gene approaches to linkage in PD families have not been rewarding, a genome wide scan mapped PD to 4q21-23 in one large family with PD with diffuse Lewy bodies, where a candidate gene, alpha-synuclein, resides, This gene encodes a presynaptic protein of which a peptide fragment is known to be a constituent of Alzheimer's disease plaques, The identification of a missense mutation in the alpha-synuclein gene in four independent PD families suggests that at least some fraction of familial PD with diffuse Lewy bodies is the result of an abnormal protein that interferes with normal protein degradation leading to the development of inclusions and ultimately neuronal cell death. There may be common pathogenetic mechanisms involved in alpha-synuclein mutations in PD and beta-amyloid and presenilin gene mutations in Alzheimer's disease.
引用
收藏
页码:1687 / 1691
页数:5
相关论文
共 71 条
  • [31] TWIN STUDIES AND THE GENETICS OF PARKINSONS-DISEASE - A REAPPRAISAL
    JOHNSON, WG
    HODGE, SE
    DUVOISIN, R
    [J]. MOVEMENT DISORDERS, 1990, 5 (03) : 187 - 194
  • [32] Mitochondrial DNA polymorphism in substantia nigra
    Kapsa, RMI
    JeanFrancois, MJB
    Lertrit, P
    Weng, S
    Siregar, N
    Ojaimi, J
    Donnan, G
    Masters, C
    Byrne, E
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 144 (1-2) : 204 - 211
  • [33] GENETIC-EVIDENCE THAT THE LEWY BODY VARIANT IS INDEED A PHENOTYPIC VARIANT OF ALZHEIMERS-DISEASE
    KATZMAN, R
    GALASKO, D
    SAITOH, T
    THAL, LJ
    HANSEN, L
    [J]. BRAIN AND COGNITION, 1995, 28 (03) : 259 - 265
  • [34] Dementia with Lewy bodies
    Kosaka, K
    Iseki, E
    [J]. CURRENT OPINION IN NEUROLOGY, 1996, 9 (04) : 271 - 275
  • [35] CHRONIC PARKINSONISM IN HUMANS DUE TO A PRODUCT OF MEPERIDINE-ANALOG SYNTHESIS
    LANGSTON, JW
    BALLARD, P
    TETRUD, JW
    IRWIN, I
    [J]. SCIENCE, 1983, 219 (4587) : 979 - 980
  • [36] A CLINICAL GENETIC-STUDY OF PARKINSONS-DISEASE - EVIDENCE FOR DOMINANT TRANSMISSION
    LAZZARINI, AM
    MYERS, RH
    ZIMMERMAN, TR
    MARK, MH
    GOLBE, LI
    SAGE, JI
    JOHNSON, WG
    DUVOISIN, RC
    [J]. NEUROLOGY, 1994, 44 (03) : 499 - 506
  • [37] BRAIN, SKELETAL-MUSCLE AND PLATELET HOMOGENATE MITOCHONDRIAL-FUNCTION IN PARKINSONS-DISEASE
    MANN, VM
    COOPER, JM
    KRIGE, D
    DANIEL, SE
    SCHAPIRA, AHV
    MARSDEN, CD
    [J]. BRAIN, 1992, 115 : 333 - 342
  • [38] Anticipation in familial Parkinson's disease - A reanalysis of 13 United Kingdom kindreds
    Maraganore, DM
    Schaid, DJ
    Rocca, WA
    Harding, AE
    [J]. NEUROLOGY, 1996, 47 (06) : 1512 - 1517
  • [39] Risk of Parkinson's disease among first-degree relatives: A community-based study
    Marder, K
    Tang, MX
    Mejia, H
    Alfaro, B
    Cote, L
    Louis, E
    Groves, J
    Mayeux, R
    [J]. NEUROLOGY, 1996, 47 (01) : 155 - 160
  • [40] Mark MH, 1996, ADV NEUROL, V69, P315